1 / 13

Joint Meeting of CMO and AMR - NFP Discussion and Conclusions

Antimicrobial resistance (AMR) is a critical health concern in Europe and globally, with rising levels observed from 2001 to 2005. Evidence shows a direct correlation between antibiotic use and AMR across EU member states. Key recommendations include developing national strategies, enhancing local ownership, establishing inter-sectorial committees, and improving surveillance on antibiotic use and resistance. To combat AMR effectively, promoting proper hygiene and awareness campaigns along with consistent follow-ups and EU-level initiatives is imperative. Collaboration among health stakeholders is essential for managing this pressing issue.

ted
Télécharger la présentation

Joint Meeting of CMO and AMR - NFP Discussion and Conclusions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Joint Meeting of CMO and AMR-NFPDiscussion and Conclusions Marija Seljak, Director General of Public Health Ministry of Health eu2008.si

  2. Antimicrobial resistance remains one of the serious European and global health problem • In most MS between 2001 and 2005 an increase of the burden of antimicrobial resistance can be observed (EARSS)

  3. marked differences in AB use between EU countries and in the types of AB that are used • consistent association between the level of use of certain AB and resistance to these AB has been reported confirming the suspected relationship between AB use and AMR in EU countries

  4. Recommendations on prudent use of antimicrobials in human medicine adopted in 2001 • MS,European Commission and EU agencies (ECDC, EFSA, EMEA,…) have taken variety of actions

  5. What are the areas of the Recommendations where the actions need to be improved?

  6. Need for… • developing national strategy with translation to action plan • ensuring ownership at the local level

  7. Need for… • Setting up inter-sectorial mechanism, e.g. a national committee, involving all relevant stakeholders with the clear mandate and political support

  8. Need for… • Strengthening surveillance systems and data quality on antimicrobial resistance, use of antimicrobial agents and healthcare-associated infections

  9. Need for… • Promoting good hygiene practices for the control of the transmission multidrug resistance bacteria

  10. Need for… • Promoting prudent use of antibiotics through awareness campaigns with credible, scientifically based messages and actions, aimed at the practitioners and general public and include information about the risk of self-medication

  11. Need for at EU level… • Follow – up on the implementation of Council Recommendations • Continue with “Health in all policies approach” in this area through EU initiatives

  12. Need for at EU level • Continue with activities within the ECDC in this area (country visits, recommendations, scientific work, surveillance) • Exchange of best practices among MS • Antibiotic Awareness Day

  13. HVALA! THANK YOU! eu2008.si

More Related